Suppression of PI3K/Akt/mTOR Signaling Pathway and Antioxidant System and Reversal of Cancer Cells Resistance to Cisplatin under the Effect of Curcumin

被引：0
|
作者：
E. V. Kalinina
A. A. Sh. Hasan
V. V. Tatarskiy
Yu. L. Volodina
А. S. Petrova
M. D. Novichkova
D. D. Zhdanov
N. K. Nurmuradov
N. N. Chernov
A. A. Shtil
机构：
[1] Peoples’ Friendship University of Russia (RUDN University),T. T. Berezov Department of Biochemistry
[2] Ministry of Health of the Russian Federation,Laboratory of Tumor Cell Death, N. N. Blokhin National Medical Research Center of Oncology
来源：
Bulletin of Experimental Biology and Medicine | 2022年 / 173卷
关键词：
tumor cells drug resistance; gene expression; PI3K/AkT/mTOR signaling pathway; cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The effect of curcumin on the resistance of SKOV-3 human ovarian adenocarcinoma cells to cisplatin was studied. It was found that curcumin induced “reversal” of cancer cells resistance, which was associated with suppression of the expression of genes encoding the key antioxidant enzymes (SOD1, SOD2, CAT, GPX1, and HO-1) and transcription factor Nrf2 and a decrease in the expression of genes encoding kinases of the PI3K/Akt/mTOR signaling pathway. The obtained results confirm the role of redox-dependent regulation in the “reversal” of cancer cells resistance to cisplatin.
引用
收藏
页码：371 / 375
页数：4
相关论文
共 50 条
  • [41] The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer
    Zhang, Wenyuan
    Zhou, Qing
    Wei, Yunhai
    Da, Miao
    Zhang, Chun
    Zhong, Jing
    Liu, Jin
    Shen, Junjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (07): : 2474 - 2484
  • [42] Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
    Chang, Lei
    Graham, Peter H.
    Ni, Jie
    Hao, Jingli
    Bucci, Joseph
    Cozzi, Paul J.
    Li, Yong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 507 - 517
  • [43] 'Investigation of miRNAs That Affect the PI3K/AKT/mTOR Signaling Pathway in Endometrial Cancer'
    Oz, Hasan
    Canacankatan, Necmiye
    Antmen, Serife Efsun
    Aytan, Hakan
    Tuncel, Ferah
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2025,
  • [44] PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
    Liu, Hua
    Zhang, Liqin
    Zhang, Xuyan
    Cui, Zhumei
    ONCOTARGETS AND THERAPY, 2017, 10 : 2865 - 2871
  • [45] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [46] PI3K/Akt/mTOR pathway as a target for cancer therapy
    Morgensztern, D
    McLeod, HL
    ANTI-CANCER DRUGS, 2005, 16 (08) : 797 - 803
  • [47] miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway
    Gu, Yifan
    Fei, Zhewei
    Zhu, Ronghua
    ANTI-CANCER DRUGS, 2020, 31 (04) : 385 - 393
  • [48] PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
    Li, Xiaoman
    Wu, Changjing
    Chen, Nianci
    Gu, Huadi
    Yen, Allen
    Cao, Liu
    Wang, Enhua
    Wang, Liang
    ONCOTARGET, 2016, 7 (22) : 33440 - 33450
  • [49] PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
    Navaei, Zahra Nasrpour
    Khalili-Tanha, Ghazaleh
    Zangouei, Amir Sadra
    Abbaszadegan, Mohammad Reza
    Moghbeli, Meysam
    ONCOLOGY RESEARCH, 2021, 29 (04) : 235 - 250
  • [50] Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors
    Welker, Mark E.
    Kulik, George
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4063 - 4091
12345